Get started
Author

Thomas Riemer

Observed names: Riemer Thomas, Riemer, Thomas, T Riemer, T. Riemer
ORCID: 0000-0001-6284-8021
Observed ORCID: 0000-0001-6284-8021
OpenAlex ID: A5103165491
Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R)
2017 · Holger Nef, Jens Wiebe, et al. · EuroIntervention · 17
PDF
Clinical restenosis and its predictors after implantation of everolimus-eluting bioresorbable vascular scaffolds: results from GABI-R
2017 · Julinda Mehilli, Stephan Achenbach, et al. · EuroIntervention · 9
PDF
Predictors of early scaffold thrombosis
2018 · Jochen Wöhrle, Holger M. Nef, et al. · Coronary Artery Disease · 8
Current status of antithrombotic therapy and in-hospital outcomes in patients with atrial fibrillation undergoing percutaneous coronary intervention in Germany
2022 · Uwe Zeymer, Ralph Toelg, et al. · Herz · 5
Impact of Access Site on Periprocedural Bleeding and Cerebral and Coronary Events in High-Bleeding-Risk Percutaneous Coronary Intervention: Findings from the RIVA-PCI Trial
2023 · Martin Borlich, Uwe Zeymer, et al. · Cardiology and Therapy · 3
PDF
Rivaroxaban in Patients With Atrial Fibrillation Who Underwent Percutaneous Coronary Intervention in Clinical Practice
2022 · Uwe Zeymer, Ralph Toelg, et al. · The American Journal of Cardiology · 3
No Difference in 30-Day Outcome and Quality of Life in Transradial Versus Transfemoral Access – Results From the German Austrian ABSORB Registry (GABI-R)
2021 · Bastian Wein, Myron Zaczkiewicz, et al. · Cardiovascular revascularization medicine · 3
Design of the multicentre randomised controlled BENTO trial to demonstrate patient-relevant benefit of bronchoscopic lung volume reduction using thermal vapour ablation in the German healthcare system for patients with upper lobe emphysema: a study protocol
2024 · Konstantina Kontogianni, Kaid Darwiche, et al. · BMJ Open · 2
Quality of life of patients with coronary heart disease treated with the bioresorbable vascular scaffold (ABSORB™): 2-year results from the GABI-R-registry
2022 · Kathrin Pahmeier, Silke Neusser, et al. · BMC Cardiovascular Disorders · 2
PDF
Outcomes of 10,312 patients treated with everolimus‐eluting bioresorbable scaffolds during daily clinical practice – results from the European Absorb Consortium
2021 · Jens Wiebe, Felix J. Hofmann, et al. · Catheterization and Cardiovascular Interventions · 2
PDF
Predictors of scaffold failure and impact of optimized scaffold implantation technique on outcome: Results from the German‐Austrian ABSORB RegIstRy
2021 · Niklas F. Boeder, Johannes Kastner, et al. · Catheterization and Cardiovascular Interventions · 2
Comparison between treatment of “established” versus complex “off-label” coronary lesions with Absorb® bioresorbable scaffold implantation: results from the GABI-R® registry
2019 · Aydin Huseynov, Stefan Baumann, et al. · Clinical Research in Cardiology · 2
Two year efficacy and safety of small versus large ABSORB bioresorbable vascular scaffolds of ≤18 mm device length: A subgroup analysis of the German-Austrian ABSORB RegIstRy (GABI-R)
2020 · Myron Zaczkiewicz, Bastian Wein, et al. · IJC Heart & Vasculature · 1
PDF
Impact of coronary calcification on outcomes after ABSORB scaffold implantation: insights from the GABI-R registry
2020 · Rayyan Hemetsberger, Mohammad Abdelghani, et al. · Coronary Artery Disease · 1
Hybrid Coronary Percutaneous Treatment with Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-Years Results from the GABI-R Registry
2019 · Tommaso Gori, Stephan Achenbach, et al. · Journal of Clinical Medicine · 1
PDF
PP.40.04
2015 · A. Jumar, R. Dechend, et al. · Journal of Hypertension · 1
Killip class at presentation and immediate versus staged multivessel PCI in patients with STEMI
2026 · Philipp Jakob, Ferdinando Varbella, et al. · Scientific Reports
PDF
Real-world characteristics and management of ventricular tachycardias in ICD patients: Data from the VIDEO registry
2026 · Fabienne Kreimer, Julian Wolfes, et al. · Clinical Research in Cardiology
PDF
The assessment of indications for percutaneous coronary intervention: a multicenter analysis after the diagnosis of chronic coronary syndrome
2026 · Uwe Zeymer, Natalia Kelsch, et al. · Deutsches Ärzteblatt international
PDF
Hospitalization profiles and complications across icd and CRT-D implantations in germany: data from the video STUDY
2026 · T Aktemur Ozalp, K Ukita, et al. · EP Europace
Hospitalization profiles and complications across ICD and CRT-D implantations in Germany: data from the VIDEO study
2026 · Tugba Aktemur Oezalp, Kohei Ukita, et al. · Clinical Research in Cardiology
PDF
Nationwide Multicentric Analysis Regarding In-Hospital Complications After Catheter Ablation of Cardiac Arrhythmias
2026 · Florian Doldi, Christian Meyer, et al. · Journal of Cardiovascular Development and Disease
PDF
Impact of renal dysfunction on immediate versus staged revascularization of non-culprit lesions in patients with ST segment elevation myocardial infarction: a pre-specified subgroup analysis of the randomized MULTISTARS AMI trial
2026 · Miklos Rohla, Kurt Huber, et al. · Clinical Research in Cardiology
Impact of Renal Function Estimation Formulae on Use and Correct Dosing of NOACs in Patients with Non-valvular Atrial Fibrillation in Real Life in Germany
2024 · Uwe Zeymer, Thomas Riemer, et al. · American Journal of Cardiovascular Drugs
P798Outcome of percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in patients with STEMI as compared to stable CAD 2 year results from the German-Austrian ABSORB
2018 · M Troebs, S Achenbach, et al. · European Heart Journal
Works count: 30
Citation count: 62
H-index: 4
I10-index: 1
Year
Topic
Type